Results 141 to 150 of about 310,804 (186)

A comparison of anti-cyclic citrullinated peptides (CCP3 and CCP3.1) autoantibody tests in rheumatoid arthritis. [PDF]

Pract Lab Med
Nelson HA, Banerjee D, Novis CL, Deane KD, Feser ML, Nandakumar V.   +5 more
europepmc   +1 more source

Towards peptide-binding peptides

, 2001
textPeptide-binding peptides can be a very powerful research tool. A novel methodology, based on the mechanism of bacteriophage l switch in E. coli and combinatorial screening, has been developed to isolate peptides that bind another target peptide in
Zhang, Zhiwen
core  

[Determination of the derivatization reactivity between α/β-dicarbonyl compounds and standard citrullinated peptides based on matrix-assisted laser desorption ionization-time-of-flight mass spectrometry]. [PDF]

Se Pu
Li YF, Zhou DD, Chen XF, Zhao JJ, Gao CL, Qiu XT, Tang ZC, Deng N, Zhao WN, Bian YY.   +9 more
europepmc   +1 more source

Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study. [PDF]

RMD Open, 2019
Boman A, Brink M, Lundquist A, Hansson M, Mathsson-Alm L, Rönnelid J, Berglin E, Holmdahl R, Skriner K, Serre G, Klareskog L, Rantapää-Dahlqvist S.   +11 more
europepmc   +1 more source

Beyond natural amino acids: extending immunogenicity risk assessment to modified peptides through chemical feature encoding. A case study on citrullination. [PDF]

Front Immunol
Cairoli M, Nielsen M, Betts C, Obrezanova O, De Maria L.   +4 more
europepmc   +1 more source

Autoantibodies and T Cells Target Citrullinated and Homocitrullinated Antigens in Rheumatoid Arthritis. [PDF]

Immunol Rev
James EA, Callebaut A, Buckner JH, Kwok WW.   +3 more
europepmc   +1 more source

Citrullination and Deamidation in Type 1 Diabetes: Linking Beta Cell Stress to Neoantigen-Driven Autoimmunity. [PDF]

Immunol Rev
Callebaut A, Bruggeman Y, Mathieu C, James EA, Overbergh L.   +4 more
europepmc   +1 more source

Protective and Pathogenic Antibodies to Citrullinated Antigens. [PDF]

Immunol Rev
Sareila O, He Y, Xu Z, Ge C, Lönnblom E, Holmdahl R.   +5 more
europepmc   +1 more source

Cellular Consequences, Citrullination Substrates, and Antigenicity of Targeting PAD4 to Cell Surfaces. [PDF]

ACS Cent Sci
Kong S, Peters-Clarke TM, Delaveris CS, Phojanakong P, Steri V, Wells JA.   +5 more
europepmc   +1 more source

Antigen-Specific Tolerization in Rheumatoid Arthritis: Evaluating the Translational Potential of hPAD4 Plasmid Therapy. [PDF]

Int J Rheum Dis
Cheng TK, Kameda H, Wei JC.
europepmc   +1 more source